A Phase 1 Open-label, Non-randomized, Single Ascending Dose Escalation Study To Evaluate The Pharmacokinetics, Safety, And Tolerability Of A Ralinepag Extended Release (XR) Tablet Formulation In Healthy Chinese Subjects
A Phase 1 Open-label, Non-randomized, Single Ascending Dose Escalation Study To Evaluate The Pharmacokinetics, Safety, And Tolerability Of A Ralinepag Extended Release (XR) Tablet Formulation In Healthy Chinese Subjects.
100 项与 Everstar Medicines Shanghai Ltd. 相关的临床结果
0 项与 Everstar Medicines Shanghai Ltd. 相关的专利（医药）
100 项与 Everstar Medicines Shanghai Ltd. 相关的药物交易
100 项与 Everstar Medicines Shanghai Ltd. 相关的转化医学
